Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Nasterlack

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
International Archives of Occupational and Environmental Health|July 14, 2006
Epidemiological and clinical investigations among employees in a former herbicide production processMichael Nasterlack, Gerhard Hoffmann, Peter Messerer, et al.
Journal of Occupational and Environmental Medicine|February 12, 2009
Health and safety protection for chemical industry employees in a rotating shift system: program design and acute injury and illness experience at workM Gerald Ott, Christoph Oberlinner, Stefan Lang, et al.
BJU International|January 13, 2011
The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic aminesBeate Pesch, Michael Nasterlack, Friedhelm Eberle, et al.
International Archives of Occupational and Environmental Health|October 17, 2013
Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic aminesBeate Pesch, Dirk Taeger, Georg Johnen, et al.
Plos One|April 25, 2012
Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreenGeorg Johnen, Katarzyna Gawrych, Heike Bontrup, et al.
BMC Cancer|November 22, 2014
Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening studyNadine Bonberg, Beate Pesch, Thomas Behrens, et al.
Urologic Oncology|May 25, 2012
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-StudySeverine Banek, Christian Schwentner, Dirk Täger, et al.
BJU International|January 29, 2013
Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen studyNadine Bonberg, Dirk Taeger, Katarzyna Gawrych, et al.
BJU International|February 9, 2012
Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen studySeverine Huber, Christian Schwentner, Dirk Taeger, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Archives of Occupational and Environmental Health|July 14, 2006
Epidemiological and clinical investigations among employees in a former herbicide production processMichael Nasterlack, Gerhard Hoffmann, Peter Messerer, et al.
Journal of Occupational and Environmental Medicine|February 12, 2009
Health and safety protection for chemical industry employees in a rotating shift system: program design and acute injury and illness experience at workM Gerald Ott, Christoph Oberlinner, Stefan Lang, et al.
BJU International|January 13, 2011
The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic aminesBeate Pesch, Michael Nasterlack, Friedhelm Eberle, et al.
International Archives of Occupational and Environmental Health|October 17, 2013
Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic aminesBeate Pesch, Dirk Taeger, Georg Johnen, et al.
Plos One|April 25, 2012
Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreenGeorg Johnen, Katarzyna Gawrych, Heike Bontrup, et al.
BMC Cancer|November 22, 2014
Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening studyNadine Bonberg, Beate Pesch, Thomas Behrens, et al.
Urologic Oncology|May 25, 2012
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-StudySeverine Banek, Christian Schwentner, Dirk Täger, et al.
BJU International|January 29, 2013
Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen studyNadine Bonberg, Dirk Taeger, Katarzyna Gawrych, et al.
BJU International|February 9, 2012
Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen studySeverine Huber, Christian Schwentner, Dirk Taeger, et al.
Pageof 3